A carregar...
Recalcitrant Atopic Dermatitis Treated with Omalizumab
Atopic dermatitis (AD) is a chronic cutaneous inflammatory disease. Various categories of therapeutic medications are used for treating AD. Omalizumab is a monoclonal anti-IgE antibody that binds to IgE molecules at the high-affinity receptor (FcεRI) binding site. Therefore, omalizumab can be used a...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Korean Dermatological Association; The Korean Society for Investigative Dermatology
2010
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2917695/ https://ncbi.nlm.nih.gov/pubmed/20711278 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5021/ad.2010.22.3.349 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|